TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
131.21
+3.95 (3.10%)
Aug 12, 2025, 4:00 PM - Market closed
TransMedics Group Market Cap
TransMedics Group has a market cap or net worth of $4.47 billion as of August 12, 2025. Its market cap has decreased by -8.97% in one year.
Market Cap
4.47B
Enterprise Value
4.59B
1-Year Change
-8.97%
Ranking
Category
Stock Price
$131.21
Market Cap Chart
Since May 2, 2019, TransMedics Group's market cap has increased from $452.48M to $4.47B, an increase of 888.55%. That is a compound annual growth rate of 44.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 3.90B | 86.53% |
| Dec 31, 2024 | 2.09B | -18.79% |
| Dec 29, 2023 | 2.58B | 30.78% |
| Dec 30, 2022 | 1.97B | 270.34% |
| Dec 31, 2021 | 532.04M | -1.57% |
| Dec 31, 2020 | 540.50M | 34.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |